To investigate the role of CD23 in the pathogenesis of arthritis and the effects of blocking p30A in vivo, we used a rat model of adjuvant-induced arthritis (AIA) which shows many clinical and histopathological features close to human rheumatoid arthritis [21]. The gene discussed is FCER2; the disease is rheumatoid arthritis.